Wolverine Trading’s Agilon Health AGL Stock Holding History

Wolverine Trading’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$27.9K	Buy	1,004 +32	+3%	+$1.21K	﹤0.01%	5508
2025 Q2	$56.1K	Buy	+972	New	+$78K	﹤0.01%	4317
2024 Q3	–	Sell	-424	Closed	-$69.3K	–	4717
2024 Q2	$69.3K	Sell	424 -28	-6%	-$3.99K	﹤0.01%	4165
2024 Q1	$68.9K	Sell	452 -896	-66%	-$149K	﹤0.01%	4145
2023 Q4	$423K	Buy	1,348 +688	+104%	+$249K	﹤0.01%	3129
2023 Q3	$293K	Buy	660 +224	+51%	+$101K	﹤0.01%	3320
2023 Q2	$187K	Buy	+436	New	+$245K	﹤0.01%	3551
2023 Q1	–	Sell	-468	Closed	-$189K	–	4146
2022 Q4	$189K	Buy	+468	New	+$219K	﹤0.01%	3176

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wolverine Trading's AGL Position: Q3 2025 in Review

Wolverine Trading increased its Agilon Health (AGL) stake by 203% in Q3 2025, buying an estimated $33K and bringing the position to 1,304 shares worth $36.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5481.

Wolverine Trading first reported a position in AGL in Q1 2022 and has held it in 4 quarters since. The position peaked at $216K in Q1 2022. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

Wolverine Trading held 1,304 shares of Agilon Health worth $36.2K as of Q3 2025.
Wolverine Trading bought 874 Agilon Health shares in Q3 2025, an estimated $33K.
Agilon Health made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5481 holding.
Wolverine Trading first reported a position in Agilon Health in Q1 2022 and has held it in 4 quarters since.
Wolverine Trading's Agilon Health position peaked at $216K in Q1 2022.
190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.